Performa HargaHarga kembali 1 minggu7.63%
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)7.69
Harga Terendah (52 Minggu)6.65
Latar Belakang Perusahaan
Perusahaan bioteknologi yang mengembangkan terapi imun (immunotherapy) dan pengobatan kanker berbasis sistem kekebalan tubuh, termasuk terapi untuk kanker kandung kemih dan berbagai jenis kanker lainnya.
Summary
Valuation Information
Current PE Ratio (TTM)-7.88
Forward PE Ratio-
Current Price to Book Value-7.53
Current Price to Sales45.39
EV to Revenue51.56
EV to EBITDA-8.99
PEG Ratio-
Per Share
Current EPS (Annualized)-0.95
Diluted EPS (TTM)-0.95
Revenue Per Share0.16
Current Book Value Per Share-0.99
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-235298000
Profit Margin0
Operating Margin-1.204
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
